​​Molecular Pathology Publications

October-December'2022​

  • Anaplastic Large-cell Lymphoma Involving Gastrointestinal Tract: A Clinicopathologic Study of 25 Cases of a Rare Tumor at a Rare Site.​​ Ud Din N, Rahim S, Ansar Z, Ahmed A and Ahmad Z. ​​2022 Dec 13:10668969221137518.​ ​​DOI: 10.1177/10668969221137518.​


  • Tuberculosis and diabetes mellitu​s: Relating immune impact of co-morbidity with challenges in disease management in high burden countries. ​​Abbas U, Masood KI, Khan A, Irfan M, Saifullah N, Jamil B and Hasan Z.​ ​J Clin Tuberc Other Mycobact Dis. 2022 Nov 29;29:100343. DOI: 10.1016/j.jctube.2022.100343.


  • ​Identifying the c​​urrent status and future needs of clinical, educational, and laboratory genetics services in Pakistan: a web-based panel discussion. Ashfaq M, Ahmed SA, Aziz-Rizvi R, Hasan Z, Kirmani S, Munim S, Naeem R, Raza J and​ Furqan A. ​J Community Genet. 2022 Oct 20. DOI: 10.1007/s12687-022-00615-x.​


​July-September'2022​

  • ​Spectrum of Cystic Fibrosis Conductance Regulator Gene Mutations Reported in Pakistani Descent Cystic Fibrosis Patients. Majid H, Khan AH, Hashmi SB, Moatter T and Nasir A. J Coll Physicians Surg Pak. 2022 Aug;32(8):1042-1046. ​​DOI: 10.29271/jcpsp.2022.08.​​1042​.​​​​


​April-June'2022​

  • COVID-19 age-dependent immunology and clinical outcomes: implications for vaccines. Sarfraz A, Hasan Siddiqui S, Iqbal J, Ali SA, Hasan Z, Sarfraz Z and Iqbal NT. J Dev Orig Health Dis. 2022 Jun;13(3):277-283. doi: 10.1017/S2040174421000398. Epub 2021 Jul 21. PMID: 34284839. DOI: 10.1017/S2040174421000398.


  • Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan. Napier G, Khan AS, Jabbar A, Khan MT, Ali S, Qasim M, Mohammad N, Hasan R, Hasan Z, Campino S, Ahmad S, Khattak B, Waddell SJ, Khan TA, Phelan JE, Clark TG. Sci Rep. 2022 May 11;12(1):7703. doi: 10.1038/s41598-022-11795-4. PMID: 35545649; PMCID: PMC9095715. DOI: 10.1038/s41598-022-11795-4​


  • ​​​Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)-3 in the diabetic host. Masood KI, Irfan M, Masood Q, Yameen M, Jamil B, Ram N, Rao S, Rottenberg M and Hasan Z. Scandinavian journal of immunology. 2022 April;95(4), e13134. https://doi.org/10.1111/sji.13134.


  • ​The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: Walker TM, Miotto P, Köser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M and Rodwell TC. (2022). A genotypic analysis. The Lancet. Microbe. 2022 April;3(4), e265–e273. https://doi.org/10.1016/S2666-5247(21)00301-3. (Dr. Zahra Hasan Collaboration)​​​​